119 related articles for article (PubMed ID: 8103459)
1. A pharmacological analysis of the effects of (+)-AJ 76 and (+)-UH 232 at release regulating pre- and postsynaptic dopamine receptors.
Gifford AN; Johnson KM
Eur J Pharmacol; 1993 Jun; 237(2-3):169-75. PubMed ID: 8103459
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.
Piercey MF; Lum JT
Eur J Pharmacol; 1990 Jul; 182(2):219-26. PubMed ID: 2397740
[TBL] [Abstract][Full Text] [Related]
3. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
Sotnikova TD; Gainetdinov RR; Grekhova TV; Rayevsky KS
Pharmacol Res; 2001 Mar; 43(3):283-90. PubMed ID: 11401421
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors labelled by [3H]quinpirole.
Seeman P; Schaus JM
Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
[TBL] [Abstract][Full Text] [Related]
5. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.
Svensson K; Johansson AM; Magnusson T; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):234-45. PubMed ID: 2880302
[TBL] [Abstract][Full Text] [Related]
6. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
7. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
8. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry.
Palij P; Bull DR; Sheehan MJ; Millar J; Stamford J; Kruk ZL; Humphrey PP
Brain Res; 1990 Feb; 509(1):172-4. PubMed ID: 2137719
[TBL] [Abstract][Full Text] [Related]
10. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson AM; Eriksson E
Eur J Pharmacol; 1986 Nov; 130(3):237-42. PubMed ID: 3792447
[TBL] [Abstract][Full Text] [Related]
11. The preferential dopamine D3 receptor ligand, (+)-UH232, is a partial agonist.
Griffon N; Pilon C; Schwartz JC; Sokoloff P
Eur J Pharmacol; 1995 Aug; 282(1-3):R3-4. PubMed ID: 7498261
[TBL] [Abstract][Full Text] [Related]
12. Effects of D3/D2 dopamine receptor agonists and antagonists on prepulse inhibition of acoustic startle in the rat.
Caine SB; Geyer MA; Swerdlow NR
Neuropsychopharmacology; 1995 Apr; 12(2):139-45. PubMed ID: 7779242
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of liberation and metabolism of dopamine in the dorsal striatum of free-living rats: the role of D2- and D3-dopamine autoreceptors].
Gaĭnetdinov RR; Sotnikova TD; Grekhova TV; Raevskiĭ KS
Dokl Akad Nauk; 1994 Aug; 337(6):821-3. PubMed ID: 7981645
[No Abstract] [Full Text] [Related]
14. Comparison of the role of local anesthetic properties with dopamine uptake blockade in the inhibition of striatal and nucleus accumbens [3H]acetylcholine release by cocaine.
Gifford AN; Johnson KM
J Pharmacol Exp Ther; 1992 Nov; 263(2):757-61. PubMed ID: 1359115
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
Waters N; Lagerkvist S; Löfberg L; Piercey M; Carlsson A
Eur J Pharmacol; 1993 Sep; 242(2):151-63. PubMed ID: 8253112
[TBL] [Abstract][Full Text] [Related]
16. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
Santiago M; Westerink BH
Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
[TBL] [Abstract][Full Text] [Related]
17. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
Henselmans JM; Hoogland PV; Stoof JC
Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
[TBL] [Abstract][Full Text] [Related]
18. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232.
Cooper SJ; Rusk IN; Barber DJ
Physiol Behav; 1989 Jun; 45(6):1263-6. PubMed ID: 2573095
[TBL] [Abstract][Full Text] [Related]
19. Biochemical profile of risperidone, a new antipsychotic.
Leysen JE; Gommeren W; Eens A; de Chaffoy de Courcelles D; Stoof JC; Janssen PA
J Pharmacol Exp Ther; 1988 Nov; 247(2):661-70. PubMed ID: 2460616
[TBL] [Abstract][Full Text] [Related]
20. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
Biochem Pharmacol; 1988 May; 37(10):2077-84. PubMed ID: 2967702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
